[1]Lin Zhongqiu，Wang Lijuan，Liu Longyang.Interpretation of international federation of gynecology and obstetrics 2012 guidelines for the diagnosis and treatment of cervical cancer［J］.Chinese Journal of Practical Gynecology and Obstetrics，2013，29(5)：323-325.［林仲秋，王丽娟，刘龙阳.国际妇产科联盟2012宫颈癌诊治指南解读［J］.中国实用妇科与产科杂志，2013，29（5）：323-325.］
[2]Li Xuemei，Chi Da，Tong Rui.Value of CT perfusion parameters changes in the evalution of sensitivity before and after radiotherapy and chemotherapy for cervical cancer［J］.Chinese Journal of CT and MRI，2016，14(2)：91-93.［李雪梅，迟达，佟锐.宫颈癌放化疗前后CT灌注参数变化对放化疗敏感性的评价［J］.中国CT和MRI杂志，2016，14（2）：91-93.］
[3]Jain RK，Martin JD，Stylianopoulos T.The role of mechanical forces in tumor growth and therapy［J］.Annu Rev Biomed Eng，2014，16：321-346.
[4]Hudson JM，Bailey C，Atri M，et al.The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT，-MRI and-US in patients with metastatic renal cell carcinoma receiving sunitinib［J］.Eur Radiol，2018，28(6)：2281-2290.
[5]Othman AE，Afat S，Nikoubashman O，et al.Volume perfusion CT imaging of cerebral vasospasm：Diagnostic performance of different perfusion maps［J］.Neuroradiology，2016，58(8)：787-792.
[6]Zhou Yong，Yu Yingying，Guo Yunquan，et al.Study on correlations between CT perfusion imaging and changes of VEGF and MVD expressions of cervical cancer［J］.J Med Imaging，2015，25(2)：299-303.［周永，余莹莹，郭云泉，等.宫颈癌CT灌注成像与VEGF、MVD的相关性研究［J］.医学影像学杂志，2015，25（2）：299-303.］
[7]Ding Die，Dai Xu，Meng Xianyun，et al.Research progress of response evalution criteria in solid tumours［J］.Chin J Clin Oncol Rehabil，2015，22(9)：1150-1152.［丁婕，戴旭，孟宪运，等.实体瘤疗效评价标准的研究进展［J］.中国肿瘤临床与康复，2015，22（9）：1150-1152.］
[8]Chen WQ，Zheng RS，Zeng H，et al.The updated incidences and mortalities of major cancers in China，2011［J］.Chin J Cancer，2015，34(11)：502-507.
[9]Li XS，Fan HX，Zhu HX，et al.The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer［J］.Eur Radiol，2012，22(3)：617-624.
[10]Kim SH，Kamaya A，Willmann JK.CT perfusion of the liver：Principles and applications in oncology［J］.Radiology，2014，272：322-344.
[11]Yin Liang，Guo Shunlin，Guo Jigang，et al.A preliminary study on predicting the efficacy of neoadjuvant chemotherapy for cervical cancer with CT perfusion imaging［J］.International Journal of Medical Radiology，2015，38(3)：205-208.［殷亮，郭顺林，郭吉刚，等.CT灌注成像预测宫颈癌新辅助化疗疗效的初步研究［J］.国际医学放射学杂志，2015，38（3）：205-208.］
[12]He L，Wu L，Su G，et al.The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer［J］.Gynecol Oncol，2014，134：419-425.
[13]Takekida S，Fujiwara K，Nagao S，et al.Phase Ⅱ study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer［J］.Int J Gynecol Cancer，2010，20：1563-1568.
[14]Fu C，Feng XY，Bian DJ，et al.Basic T1 perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer［J］.Int J Gynecol Cancer，2013，23(7)：1270-1278.
[15]Wang Xiaoyu，Wang Yue，Yu Tao，et al.Primary study on perfusion-weighted imaging in concurrent chemoradiotherapy of cervical cancer［J］.Oncoradiology，2016，25(1)：75-80.［王晓煜，王 越，于 韬，等.磁共振灌注加权成像评价宫颈癌同步放化疗疗效的初步研究［J］.肿瘤影像学，2016，25（1）：75-80.］
[16]Rana L，Sharma S，Sood S，et al.Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma：Comparison of CT perfusion parameters before and after chemoradiation therapy［J］.Eur J Radiol Open，2015，2：46-54.
[17]Han Wenguang，Zhou Yong，Wang Hongmei，et al.The value of perfusion CT in assessing the response of local advanced cervical squamous cancer to neoadjuvant chemotherapy［J］.J Pract Radiol，2015，31(9)：1479-1482.［韩文广，周永，王红梅，等.CT灌注在局部晚期宫颈鳞癌新辅助化疗疗效评价中的价值［J］.实用放射学杂志，2015，31（9）：1479-1482.］
[18]Liu J，Fan H，Qiu GP.Vascular permeability determined using multi-slice spiral CT perfusion can predict response to chemoradiotherapy in patients with advanced cervical squamous cell carcinoma［J］.Int J Clin Pharmacol Ther，2017，55(7)：619-626.